Nicardipine Continuous Infusion Dosing for Acute Hypertension
Start nicardipine at 5 mg/hr IV and titrate by 2.5 mg/hr every 5-15 minutes to a maximum of 15 mg/hr, targeting a 10-15% reduction in mean arterial pressure within the first hour, not exceeding 25% reduction in 24 hours. 1
Initial Dosing Protocol
- Starting rate: Begin at 5 mg/hr through a central line or large peripheral vein 1, 2
- Titration increments: Increase by 2.5 mg/hr every 5-15 minutes based on urgency 1
- Maximum dose: 15 mg/hr is the absolute ceiling regardless of clinical scenario 1, 4
- Onset of action: Blood pressure begins to fall within 5-15 minutes, reaching approximately 50% of ultimate decrease in 45 minutes 5, 2
Blood Pressure Targets by Clinical Context
General Hypertensive Emergency
- Target a 10-15% reduction in mean arterial pressure within the first hour 1, 4
- Do not exceed 25% reduction in the first 24 hours to avoid organ hypoperfusion 1, 4
- Avoid normalizing blood pressure acutely in patients with chronic severe hypertension, as autoregulation of tissue perfusion is disturbed 5
Acute Ischemic Stroke (Pre-thrombolytic)
- Target <185/110 mmHg before rtPA administration 5, 4, 3
- Do not administer rtPA if blood pressure cannot be maintained below this threshold at maximum nicardipine dose 4
Acute Ischemic Stroke (Post-thrombolytic)
Acute Intracerebral Hemorrhage
- Target systolic blood pressure 130-140 mmHg for patients presenting with SBP 150-220 mmHg 5
- Avoid excessive reduction below 130 mmHg, which is potentially harmful 5
Acute Aortic Dissection
- Target systolic blood pressure <120 mmHg within the first hour 5
- Critical pitfall: Add beta-blockade first to prevent reflex tachycardia before starting nicardipine 5, 3
Monitoring Requirements
During Active Titration
- Check blood pressure every 15 minutes during dose adjustments 5, 4
- Once stable at a constant rate, extend to every 30 minutes 4
Post-Thrombolytic Stroke Patients (Intensive Protocol)
- Every 15 minutes for the first 2 hours 1, 5, 4
- Every 30 minutes for the next 6 hours 1, 5, 4
- Every hour for the subsequent 16 hours 1, 5, 4
General Monitoring
- Monitor heart rate continuously, as nicardipine typically increases heart rate by approximately 10 beats/minute 6
- Change infusion site every 12 hours if administered via peripheral vein to prevent phlebitis 2, 6
Maintenance Dosing
- Once target blood pressure is achieved, reduce to 3 mg/hr as a maintenance dose 5, 2
- Adjust the infusion rate as needed to maintain desired response 2
- Sustained blood pressure control at a constant infusion rate is maintained for 4-6 hours during continuous infusion 5
Preparation and Administration
Single Dose Vials
- Dilute each 25 mg vial with 240 mL of compatible IV fluid to achieve a concentration of 0.1 mg/mL 2
- Compatible fluids include D5W, D5W with 0.45% or 0.9% NaCl, 0.45% or 0.9% NaCl alone 2
- Not compatible with sodium bicarbonate 5% or lactated Ringer's 2
Premixed Flexible Containers
- No dilution required for nicardipine in 0.9% sodium chloride injection 2
- Protect from light until ready to use 2
When Maximum Dose Fails
If blood pressure remains uncontrolled at 15 mg/hr:
- First alternative: Switch to sodium nitroprusside (initial 0.3-0.5 mcg/kg/min) 1, 4
- Second alternative: Labetalol 10-20 mg IV bolus over 1-2 minutes, repeated every 10-20 minutes up to 300 mg maximum 4
- Contraindication: Avoid labetalol in reactive airway disease, COPD, decompensated heart failure, or bradycardia 1
Offset of Action and Discontinuation
- After stopping the infusion, blood pressure begins to rise within 30-40 minutes regardless of infusion duration 5, 2
- Plasma levels and gradually decreasing antihypertensive effects persist for many hours 2
- If hypotension or tachycardia occurs, discontinue infusion immediately 2
- Once blood pressure and heart rate stabilize, restart at low doses (3-5 mg/hr) and retitrate 2
Critical Pitfalls to Avoid
- Do not titrate too aggressively: Precipitous blood pressure drops can cause stroke or organ hypoperfusion in patients with chronic severe hypertension 5
- Avoid large blood pressure fluctuations: Excessive variability in the first 24 hours is associated with poor outcomes 5
- Do not use as monotherapy in aortic dissection: Always add beta-blockade first 5, 3
- Exercise extreme caution in cerebrovascular disease: Maintain blood pressure at the higher end of acceptable ranges to preserve cerebral perfusion 5
- Change peripheral IV sites regularly: Phlebitis can develop after 14 hours at a single site 6
Special Population Considerations
Pregnancy/Pre-eclampsia
Renal Impairment
- Avoid if creatinine clearance <15 mL/min due to significantly lower systemic clearance 5
- Monitor closely when titrating in patients with impaired renal function 2
Hepatic or Cardiac Impairment
- Monitor closely when titrating in patients with congestive heart failure or impaired hepatic function 2